RN7SL525P

Across TCGA pan-cancer cohorts, RN7SL525P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RN7SL525P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RN7SL525P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL525P expression acts as an unfavorable survival marker, although some lineages such as ESCA and BLCA show a favorable association.

ESCA, BLCA, and SKCM are the cancer types where RN7SL525P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.684	0.362	<.001	104	view →
BLCA	OS	Median	All	0.710	0.561	.005	51	view →
SKCM	DFS	Quartile	II,III,IV	0.700	0.517	.011	48	view →
LAML	DFS	Tertile	All	0.427	0.627	.004	32	view →
UCS	OS	Tertile	IV	0.203	0.817	.010	30	view →
MESO	DFS	Median	IV	0.175	0.485	.003	21	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
KICH	OS	Quartile	II,III,IV	0.396	0.899	.002	16	view →
PRAD	DFS	Quartile	All	0.820	0.906	.004	14	view →
LIHC	DFS	Tertile	All	0.344	0.475	.025	9	view →
UVM	OS	Tertile	III,IV	1.000	0.736	.036	9	view →
OV	DFS	Quartile	IV	0.696	0.365	.026	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RN7SL525P–ESCA (OS)

Open the ESCA breakdown →